CN104353114A - 一种促成骨细胞功能医用钛金属及其表面改性方法 - Google Patents
一种促成骨细胞功能医用钛金属及其表面改性方法 Download PDFInfo
- Publication number
- CN104353114A CN104353114A CN201410534295.0A CN201410534295A CN104353114A CN 104353114 A CN104353114 A CN 104353114A CN 201410534295 A CN201410534295 A CN 201410534295A CN 104353114 A CN104353114 A CN 104353114A
- Authority
- CN
- China
- Prior art keywords
- titanium
- osteoblast
- solution
- modifying
- cell growth
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 title claims abstract description 96
- 239000010936 titanium Substances 0.000 title claims abstract description 96
- 229910052719 titanium Inorganic materials 0.000 title claims abstract description 96
- 210000000963 osteoblast Anatomy 0.000 title claims abstract description 32
- 230000012010 growth Effects 0.000 title claims abstract description 10
- 238000002715 modification method Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 claims abstract description 29
- 239000011248 coating agent Substances 0.000 claims abstract description 16
- 238000000576 coating method Methods 0.000 claims abstract description 16
- 238000001291 vacuum drying Methods 0.000 claims abstract description 14
- 238000004132 cross linking Methods 0.000 claims abstract description 4
- 229910052751 metal Inorganic materials 0.000 claims description 33
- 239000002184 metal Substances 0.000 claims description 33
- 210000002449 bone cell Anatomy 0.000 claims description 22
- 230000010261 cell growth Effects 0.000 claims description 20
- 210000000496 pancreas Anatomy 0.000 claims description 16
- 229920001184 polypeptide Polymers 0.000 claims description 16
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 16
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 16
- 238000007781 pre-processing Methods 0.000 claims description 15
- 239000003431 cross linking reagent Substances 0.000 claims description 14
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 10
- 230000001582 osteoblastic effect Effects 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 102000012422 Collagen Type I Human genes 0.000 claims description 7
- 108010022452 Collagen Type I Proteins 0.000 claims description 7
- 230000002255 enzymatic effect Effects 0.000 claims description 7
- 238000012986 modification Methods 0.000 claims description 6
- 230000004048 modification Effects 0.000 claims description 6
- 230000001476 alcoholic effect Effects 0.000 claims description 5
- LRWZZZWJMFNZIK-UHFFFAOYSA-N 2-chloro-3-methyloxirane Chemical compound CC1OC1Cl LRWZZZWJMFNZIK-UHFFFAOYSA-N 0.000 claims description 4
- 239000012153 distilled water Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 3
- 239000003822 epoxy resin Substances 0.000 claims description 3
- 229920000647 polyepoxide Polymers 0.000 claims description 3
- 238000001035 drying Methods 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000007943 implant Substances 0.000 abstract description 4
- 239000000203 mixture Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 4
- 102000029816 Collagenase Human genes 0.000 abstract description 3
- 108060005980 Collagenase Proteins 0.000 abstract description 3
- 229960002424 collagenase Drugs 0.000 abstract description 3
- 230000009931 harmful effect Effects 0.000 abstract description 3
- 239000011259 mixed solution Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 description 12
- 230000000694 effects Effects 0.000 description 9
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 5
- 230000003013 cytotoxicity Effects 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000006870 function Effects 0.000 description 3
- 238000011534 incubation Methods 0.000 description 3
- 239000004971 Cross linker Substances 0.000 description 2
- 101710088194 Dehydrogenase Proteins 0.000 description 2
- 230000003915 cell function Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 206010065687 Bone loss Diseases 0.000 description 1
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000004593 Epoxy Substances 0.000 description 1
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 1
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003519 biomedical and dental material Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 239000012531 culture fluid Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 210000004513 dentition Anatomy 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 231100001083 no cytotoxicity Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 230000036346 tooth eruption Effects 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410534295.0A CN104353114B (zh) | 2014-09-30 | 2014-10-11 | 一种促成骨细胞功能医用钛金属及其表面改性方法 |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410521040 | 2014-09-30 | ||
CN2014105210400 | 2014-09-30 | ||
CN201410521040.0 | 2014-09-30 | ||
CN201410534295.0A CN104353114B (zh) | 2014-09-30 | 2014-10-11 | 一种促成骨细胞功能医用钛金属及其表面改性方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104353114A true CN104353114A (zh) | 2015-02-18 |
CN104353114B CN104353114B (zh) | 2017-02-15 |
Family
ID=52520485
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410534295.0A Active CN104353114B (zh) | 2014-09-30 | 2014-10-11 | 一种促成骨细胞功能医用钛金属及其表面改性方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104353114B (zh) |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070160681A1 (en) * | 2004-03-19 | 2007-07-12 | Park Yoon J | Bone graft and scaffolding materials immobilized with osteogenesis enhancing peptides on the surface |
WO2007092043A2 (en) * | 2006-02-02 | 2007-08-16 | Medlogics Device Corporation | Bioactive material delivery systems comprising sol-gel compositions |
CN101596329A (zh) * | 2009-07-13 | 2009-12-09 | 浙江理工大学 | 一种钛材料表面涂层的方法及其涂层复合材料的应用 |
US20110262486A1 (en) * | 2010-04-22 | 2011-10-27 | Taipei Medical University | Bone implant and manufacturing method thereof |
CN102886071A (zh) * | 2011-07-20 | 2013-01-23 | 上海纳米技术及应用国家工程研究中心有限公司 | 载银医用金属生物活性涂层及其制备方法应用 |
CN103463675A (zh) * | 2013-08-23 | 2013-12-25 | 广州军区广州总医院 | 一种抗菌抗肿瘤骨科植入材料及其制备方法 |
CN103893826A (zh) * | 2014-03-03 | 2014-07-02 | 重庆大学 | 一种调控干细胞分化及促进体内骨生成的钛合金表面改性方法 |
KR20140090962A (ko) * | 2013-01-10 | 2014-07-18 | 한양대학교 에리카산학협력단 | 항균 티타늄 임플란트의 제조방법 및 그에 따라 제조된 항균 티타늄 임플란트 |
CN104005016A (zh) * | 2014-06-06 | 2014-08-27 | 重庆大学 | 一种兼具抗菌及促成骨细胞功能的医用钛合金及其制备方法 |
-
2014
- 2014-10-11 CN CN201410534295.0A patent/CN104353114B/zh active Active
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070160681A1 (en) * | 2004-03-19 | 2007-07-12 | Park Yoon J | Bone graft and scaffolding materials immobilized with osteogenesis enhancing peptides on the surface |
WO2007092043A2 (en) * | 2006-02-02 | 2007-08-16 | Medlogics Device Corporation | Bioactive material delivery systems comprising sol-gel compositions |
CN101596329A (zh) * | 2009-07-13 | 2009-12-09 | 浙江理工大学 | 一种钛材料表面涂层的方法及其涂层复合材料的应用 |
US20110262486A1 (en) * | 2010-04-22 | 2011-10-27 | Taipei Medical University | Bone implant and manufacturing method thereof |
CN102886071A (zh) * | 2011-07-20 | 2013-01-23 | 上海纳米技术及应用国家工程研究中心有限公司 | 载银医用金属生物活性涂层及其制备方法应用 |
KR20140090962A (ko) * | 2013-01-10 | 2014-07-18 | 한양대학교 에리카산학협력단 | 항균 티타늄 임플란트의 제조방법 및 그에 따라 제조된 항균 티타늄 임플란트 |
CN103463675A (zh) * | 2013-08-23 | 2013-12-25 | 广州军区广州总医院 | 一种抗菌抗肿瘤骨科植入材料及其制备方法 |
CN103893826A (zh) * | 2014-03-03 | 2014-07-02 | 重庆大学 | 一种调控干细胞分化及促进体内骨生成的钛合金表面改性方法 |
CN104005016A (zh) * | 2014-06-06 | 2014-08-27 | 重庆大学 | 一种兼具抗菌及促成骨细胞功能的医用钛合金及其制备方法 |
Non-Patent Citations (1)
Title |
---|
XINMING ZHANG ET AL.: "Fabrication of dopamine-modified hyaluronic acid/chitosan multilayers on titanium alloy by layer-by-layer self-assembly for promoting osteoblast growth", 《APPLIED SURFACE SCIENCE》 * |
Also Published As
Publication number | Publication date |
---|---|
CN104353114B (zh) | 2017-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Annabi et al. | Highly elastic micropatterned hydrogel for engineering functional cardiac tissue | |
Park et al. | Hydrogel nanospike patch as a flexible anti-pathogenic scaffold for regulating stem cell behavior | |
WO2016060260A1 (ja) | 組織片 | |
ATE420116T1 (de) | Verfahren zur herstellung von cellulosesulfat mit verbesserten eigenschaften | |
CN104436305A (zh) | 以脱细胞生物膜为载体的心肌补片及制备方法与应用 | |
CA3136016A1 (en) | Composite biomaterials | |
CN106318904A (zh) | 间充质干细胞条件培养基用于美容品领域的用途 | |
CN102813963A (zh) | 一种以多巴胺为桥连的生物医用材料表面固定功能分子的方法 | |
CN104258468A (zh) | 一种具备抗菌性和促进成骨细胞生长的钛金属改性方法 | |
CN102058904A (zh) | 生物功能化纳米钛材及其制备方法 | |
Govoni et al. | Mechanostimulation protocols for cardiac tissue engineering | |
Tharakan et al. | Bioprinting of stem cells in multimaterial scaffolds and their applications in bone tissue engineering | |
Zhang et al. | Recent advances in cardiac patches: materials, preparations, and properties | |
CN106676607A (zh) | 一种具良好促成骨作用的二氧化钛纳米管及其制备方法 | |
Malec et al. | Effects of nanoporous anodic titanium oxide on human adipose derived stem cells | |
ATE361108T1 (de) | Verwendung eines hydrogels zum züchten von chondrozyten | |
CN109793934B (zh) | 一种组织工程化心肌补片及其制备和应用 | |
Ran et al. | Recent advances in bioinspired hydrogels with environment‐responsive characteristics for biomedical applications | |
CN103898055A (zh) | 不同基底硬度体外细胞培养平台的建立方法 | |
CN104353109B (zh) | 一种兼具抗菌性及促进成骨细胞生长的钛金属改性方法 | |
Ghasemi-Mobarakeh et al. | Embryonic stem cell differentiation to cardiomyocytes on nanostructured scaffolds for myocardial tissue regeneration | |
JP6047000B2 (ja) | 細胞を含む支持体層に培養液を灌流させることを特徴とする3次元培養組織 | |
Feldman | Biomaterial enhanced regeneration design research for skin and load bearing applications | |
CN104225679B (zh) | 一种具有抗菌性及促进成骨细胞生长的钛金属改性方法 | |
CN104324416B (zh) | 一种医用钛金属材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210201 Address after: 710000 Shaanxi Xi'an economic and Technological Development Zone, Fengcheng four road, Ming Guang road, southeast corner of the new business building 1808 Patentee after: SHAANXI ZHUANYI INTELLECTUAL PROPERTY OPERATION Co.,Ltd. Address before: 530213 No. 13 Wuhe Avenue, Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region Patentee before: Guangxi University of Chinese Medicine |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20211125 Address after: 314500 Tongxiang, Jiaxing, Zhejiang, Wutong Street East Road (East) 55, Tongxiang chamber of Commerce Building 1 unit 1702, 1703 room -D-404 Patentee after: Jiaxing Huiquan Biotechnology Co.,Ltd. Address before: 710000 Shaanxi Xi'an economic and Technological Development Zone, Fengcheng four road, Ming Guang road, southeast corner of the new business building 1808 Patentee before: SHAANXI ZHUANYI INTELLECTUAL PROPERTY OPERATION CO.,LTD. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240813 Address after: Room 1106, Building 2, Rongmin Central International, No. 99 Weiyang Road, Lianhu District, Xi'an City, Shaanxi Province, 710000 Patentee after: Xi'an zhicaiquan Technology Transfer Center Co.,Ltd. Country or region after: China Address before: 314500 Tongxiang, Jiaxing, Zhejiang, Wutong Street East Road (East) 55, Tongxiang chamber of Commerce Building 1 unit 1702, 1703 room -D-404 Patentee before: Jiaxing Huiquan Biotechnology Co.,Ltd. Country or region before: China |
|
TR01 | Transfer of patent right |